Forward looking statements are not facts"A
forward-looking statement or
safe harbor statement is a statement that cannot sustain itself as merely a historical
fact. A forward-looking statement predicts, projects, or uses future events as expectations or possibilities.
These statements can often be misleading, as they can be mistaken for factual statements, while they are actually speculation. According to
United States Code 15 Section 78u-5, a forward-looking statement may include future economic performance such as revenues or income, plans for future operations, or use of a report written by an outside reviewer."
Examples:
Below are some hypothetical examples of forward-looking statements:
- Company X plans on building a new facility in Asia by 2018, expanding our current market share.
- We anticipate the value of our company to continue to rise for over the next few years, increasing dividends for shareholders.
- We predict that our product will revolutionize the healthcare industry, improving the quality of healthcare for millions of patients.
From Limininal Release Dated February 6, 2020
Forward Looking Statement
This press release contains forward-looking statements about Liminal BioSciences' objectives, strategies and businesses and unaudited financial information that involve risks and uncertainties. Forwardlooking information includes statements concerning, among other things, statements with respect to the timing of any planned Biologics License Application filing, development of R&D programs and the timing of initiation of clinical trials.
These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, Liminal BioSciences' ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of Liminal BioSciences' to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and approvals and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations in the Annual Information Form for the year ended December 31, 2018, under the heading "Risks and Uncertainties related to Liminal BioSciences' Business". As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations.